Previous Close | 86.22 |
Open | 85.76 |
Bid | 83.01 x 900 |
Ask | 0.00 x 1000 |
Day's Range | 84.46 - 87.76 |
52 Week Range | 70.74 - 95.26 |
Volume | |
Avg. Volume | 487,283 |
Market Cap | 4.452B |
Beta (5Y Monthly) | 0.36 |
PE Ratio (TTM) | 35.63 |
EPS (TTM) | 2.46 |
Earnings Date | May 09, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 105.57 |
Haemonetics' (NYSE:HAE) stock is up by a considerable 12% over the past month. Given the company's impressive...
Recovery within the Hospital business and the favorable prospects of the Plasma franchise raise investors' optimism for Haemonetics (HAE).
Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish fourth quarter and fiscal year 2024 financial results at 6:00 am ET on Thursday, May 9, 2024. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am ET on May 9, 2024.